Is CYP1A2 useful for Wechseljahre?

Whether CYP1A2 genotype is useful for menopause (Wechseljahre) is not supported by strong evidence. CYP1A2 metabolizes caffeine and certain hormones; estrogen induces its activity, so declining estrogen during menopause can reduce CYP1A2 function, potentially increasing caffeine sensitivity. Some observational studies have explored links between CYP1A2 variants and hot flashes or sleep disturbances, but findings are inconsistent and effect sizes small. No validated DNA test provides actionable guidance for menopause management based on CYP1A2. At best, a test might indicate caffeine metabolism speed, but this does not translate into a menopause-specific recommendation. The evidence is primarily mechanistic and mixed. For menopause, established biomarkers such as hormone levels, bone density, and cardiovascular risk markers (e.g., cholesterol, hsCRP) are far more informative. Relying solely on CYP1A2 genotyping for menopause is not evidence-based. Discuss symptoms and prevention strategies with a healthcare provider rather than a direct-to-consumer DNA test.